Search Results for: client

By Kuldip K. Ambastha and Anil K. Ambastha On Thursday, December 19, 2019, Rite Aid Corporation (RAD) delivered a strong 42.3% return for the day. On that day, the company announced a quarterly earnings figure of $0.54 per share, for the quarter ending November 2019. This figure beat various consensus estimates quite significantly and thus …

Continue reading “What Caught Our Attention in the Investment World? – Week of December 16-20, 2019”

By Kuldip K. Ambastha and Anil K. Ambastha On Monday, December 9, 2019, big news emerged in the mergers & acquisitions field in terms of Merck & Co., Inc. (MRK) buying ArQule, Inc. (ARQL) and Sanofi SA (SNY) buying Synthorx Inc. (THOR). Both Merck and Sanofi bought the smaller companies to enhance their capabilities in …

Continue reading “What Caught Our Attention in the Investment World? – Week of December 9-13, 2019”

By Kuldip K. Ambastha and Anil K. Ambastha On Thursday, December 5, 2019, there was “a tale of two cities,” to quote Charles Dickens. In the biotech arena, SAGE (Sage Therapeutics, Inc.) and AUPH (Aurinia Pharmaceuticals Inc.) were big movers. Sage Therapeutics delivered -59.7% for the day, while Aurinia Pharmaceuticals returned 78.8%. SAGE-217 is a …

Continue reading “What Caught Our Attention in the Investment World? – Week of December 2-6, 2019”

By Kuldip K. Ambastha and Anil K. Ambastha Best Buy Co., Inc. (BBY), a big-box electronics retailer business headquartered in Richfield, MN, delivered strong results for 3Q2019. During the quarter, the company exceeded expectations on many fronts, such as earnings, revenues, and same-store sales. The key product and service lines which performed well were tablets, …

Continue reading “What Caught Our Attention in the Investment World? – Week of November 25-29, 2019”

By Kuldip K. Ambastha and Anil K. Ambastha Karuna Therapeutics Inc. (KRTX), a clinical-stage biopharmaceutical company, was founded in 2009 and is headquartered in Boston, MA. The company is focused on developing innovative therapies for individuals suffering from disabilities, disorders, and pain. Karuna Therapeutics Inc. has announced that its schizophrenia treatment’s Phase 2 clinical trial …

Continue reading “What Caught Our Attention in the Investment World? – Week of November 18-22, 2019”

By Kuldip K. Ambastha and Anil K. Ambastha Overstock.com, Inc. (OSTK) is an online retailer which offers a wide variety of products. Its stock fell by 17.4% on Tuesday, November 12, 2019 due to disappointing 3Q2019 results plus an investigation by the U.S. Securities and Exchange Commission (SEC). Specifically, a $0.89 loss per share was …

Continue reading “What Caught Our Attention in the Investment World? – Week of November 11-15, 2019”

By Kuldip K. Ambastha and Anil K. Ambastha Shake Shack Inc. (SHAK) is an American fast casual restaurant chain headquartered in New York, NY. The company announced its latest quarterly earnings and other key figures during this week. Same-store sales grew by 2.0% in 3Q2019, which was less than the 2.5% figure expected. The company …

Continue reading “What Caught Our Attention in the Investment World? – Week of November 4-8, 2019”

By Kuldip K. Ambastha and Anil K. Ambastha On October 28, 2019, New York-based Tiffany & Co.’s stock (TIF) jumped 31.6% for a record one-day gain. The stock surged due to the announcement of a potential $14.5 billion (USD) acquisition bid from LVMH Moët Hennessy (LVMH). LVMH is a Paris-based French company headed by the …

Continue reading “What Caught Our Attention in the Investment World? – Week of October 28-November 1, 2019”

By Kuldip K. Ambastha and Anil K. Ambastha On October 22, 2019, Biogen Inc. (BIIB) delivered a 26.1% return for the day. This was the stock’s largest one-day percentage return in 23 years. Its Alzheimer’s drug (aducanumab) had previously been written off as a failure, but now will be getting a second chance at approval …

Continue reading “What Caught Our Attention in the Investment World? – Week of October 21-25, 2019”